A ceRNA analysis on LMNA gene focusing on the Hutchinson-Gilford progeria syndrome

Journal of Clinical Bioinformatics

Volumn 3, Issue 1, 2013, Pages

  Arancio, Walter ^a   Giordano, Carla ^a   Pizzolanti, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

3' UTR; CeRNA; Hutchinson Gilford; Lamin A; LMNA; MiRNA; Progeria

Indexed keywords

EID: 84894865229     PISSN: None     EISSN: 20439113     Source Type: Journal    
DOI: 10.1186/2043-9113-3-2     Document Type: Article

References (48)

1. Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, Goldman RD. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008, 22(7):832-853. 10.1101/gad.1652708, 2732390, 18381888.
2. Arancio W. A bioinformatics analysis of Lamin-A regulatory network: a perspective on epigenetic involvement in Hutchinson-Gilford progeria syndrome. Rejuvenation Res 2012, 15(2):123-127. 10.1089/rej.2011.1250, 22533413.
3. Shimi T, Pfleghaar K, Kojima S, Pack CG, Solovei I, Goldman AE, Adam SA, Shumaker DK, Kinjo M, Cremer T, Goldman RD. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev 2008, 22(24):3409-3421. 10.1101/gad.1735208, 2607069, 19141474.
4. Ottaviani A, Schluth-Bolard C, Rival-Gervier S, Boussouar A, Rondier D, Foerster AM, Morere J, Bauwens S, Gazzo S, Callet-Bauchu E, Gilson E, Magdinier F. Identification of a perinuclear positioning element in human subtelomeres that requires A-type lamins and CTCF. EMBO J 2009, 28(16):2428-2436. 10.1038/emboj.2009.201, 2735173, 19644448.
5. Batsios P, Peter T, Baumann O, Stick R, Meyer I, Gräf R. A lamin in lower eukaryotes. Nucleus 2012, 3(3):237-243.
6. Peter A, Reimer S. Evolution of the lamin protein family: what introns can tell. Nucleus 2012, 3(1):44-59. 10.4161/nucl.18927, 22156746.
7. Constantinescu D, Gray HL, Sammak PJ, Schatten GP, Csoka AB. Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells 2006, 24(1):177-185. 10.1634/stemcells.2004-0159, 16179429.
8. Gonzalez JM, Pla D, Perez-Sala D, Andres V. A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy. Front Biosci (Schol Ed) 2011, 3:1133-1146. Review.
9. Lopez-Mejia IC, Vautrot V, De Toledo M, Behm-Ansmant I, Bourgeois CF, Navarro CL, Osorio FG, Freije JM, Stévenin J, De Sandre-Giovannoli A, Lopez-Otin C, Lévy N, Branlant C, Tazi J. A conserved splicing mechanism of the LMNA gene controls premature aging. Hum Mol Genet 2011, 20(23):4540-4555. 10.1093/hmg/ddr385, 21875900.
10. Reddy S, Comai L. Lamin A, farnesylation and aging. Exp Cell Res 2012, 318(1):1-7. Review, 10.1016/j.yexcr.2011.08.009, 21871450.
11. McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One 2007, 2(12):e1269. 10.1371/journal.pone.0001269, 2092390, 18060063.
12. Ackerman J, Gilbert-Barness E. Hutchinson-Gilford progeria syndrome: a pathologic study. Pediatr Pathol Mol Med 2002, 21(1):1-13.
13. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?. Cell 2011, 146(3):353-358. 10.1016/j.cell.2011.07.014, 3235919, 21802130.
14. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk - database: prediction of possible miRNA binding sites by "walking" the genes of 3 genomes. J Biomed Inform 2011, http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/.
15. Ritchie W, Flamant S, Rasko JE. mimiRNA: a microRNA expression profiler and classification resource designed to identify functional correlations between microRNAs and their targets. Bioinformatics 2010, 26(2):223-227. http://mimirna.centenary.org.au/mep/formulaire.html, 10.1093/bioinformatics/btp649. Epub 2009 Nov 17, 19933167.
16. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010, 38(Suppl):W214-220. 2896186, 20576703.
17. Jung HJ, Coffinier C, Choe Y, Beigneux AP, Davies BS, Yang SH, Barnes RH, Hong J, Sun T, Pleasure SJ, Young SG, Fong LG. Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA. Proc Natl Acad Sci USA 2012, 109(7):E423-431. 10.1073/pnas.1111780109, 3289373, 22308344.
18. Xia H, Ooi LL, Hui KM. MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma. PLoS One 2012, 7(9):e44206. 10.1371/journal.pone.0044206, 3433464, 22962603.
19. Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA, Cheng JQ. MiR-214 regulates ovarian cancer cell stemness by targeting p53/nanog. J Biol Chem 2012, 287(42):34970-8. 10.1074/jbc.M112.374611, 22927443.
20. Coolen M, Thieffry D, Drivenes Q, Becker TS, Bally Cuif L. miR-9 controls the timing of neurogenesis through the direct inhibition of antagonistic factors. Dev Cell 2012, 22(5):1052-1064. 10.1016/j.devcel.2012.03.003, 22595676.
21. Nissan X, Blondel S, Navarro C, Maury Y, Denis C, Girard M, Martinat C, De Sandre-Giovannoli A, Levy N, Peschanski M. Unique Preservation of Neural Cells in Hutchinson- Gilford Progeria Syndrome Is Due to the Expression of the Neural-Specific miR-9 MicroRNA. Cell Rep 2012, 2(1):1-9. 10.1016/j.celrep.2012.05.015, 22840390.
22. Provost P. Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases. Aging (Albany NY). 2010, 2(3):166-169.
23. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010, 17(2):193-199. Epub 2009 May 22. Review, 10.1038/cdd.2009.56, 19461653.
24. Paik S, Jung HS, Lee S, Yoon DS, Park MS, Lee JW. miR-449a Regulates the Chondrogenesis of Human Mesenchymal Stem Cells Through Direct Targeting of Lymphoid Enhancer-Binding Factor-1. Stem Cells Dev 2012, 21(18):3298-308. 10.1089/scd.2011.0732, 22769578.
25. Noonan EJ, Place RF, Basak S, Pookot D, Li LC. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 2010, 1(5):349-358. 2952964,2952964, 20948989.
26. Sashital DG, Doudna JA. Structural insights into RNA interference. Curr Opin Struct Biol 2010, 20(1):90-97. 10.1016/j.sbi.2009.12.001, 2855239, 20053548.
27. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009, 9(6):400-14. 10.1038/nrc2657, 2722839, 19440234.
28. Rother K, Kirschner R, Sänger K, Böhlig L, Mössner J, Engeland K. p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A. Oncogene 2007, 26(13):1949-1953. Epub 2006 Sep 25, 10.1038/sj.onc.1209989, 17001315.
29. Grossel MJ, Hinds PW. From cell cycle to differentiation: an expanding role for cdk6. Cell Cycle 2006, 5(3):266-270. 10.4161/cc.5.3.2385, 16410727.
30. Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene 2006, 25(11):1602-1611. Review, 10.1038/sj.onc.1209367, 16550160.
31. Kwong LN, Dove WF. APC and its modifiers in colon cancer. Adv Exp Med Biol 2009, 656:85-106. 10.1007/978-1-4419-1145-2_8, 19928355.
32. Frenzel A, Grespi F, Chmelewskij W, Villunger A. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis 2009, 14(4):584-96. 10.1007/s10495-008-0300-z, 3272401, 19156528.
33. Jancík S, Drábek J, Radzioch D, Hajdúch M. Clinical relevance of KRAS in human cancers. J Biomed Biotechnol 2010, 2010:150960. 2896632, 20617134.
34. Dang CV. MYC on the path to cancer. Cell 2012, 149(1):22-35. 10.1016/j.cell.2012.03.003, 22464321.
35. Redwood AB, Gonzalez-Suarez I, Gonzalo S. Regulating the levels of key factors in cell cycle and DNA repair: new pathways revealed by lamins. Cell Cycle 2011, 10(21):3652-3657. 10.4161/cc.10.21.18201, 22045204.
36. Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi MM, Mantovani A. Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb). 2011, 21(3):264-75.
37. Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev 2011, 22(4):189-195. 10.1016/j.cytogfr.2011.10.001, 22019906.
38. Stewart MW. Aflibercept (VEGF-TRAP): the next anti-VEGF drug. Inflamm Allergy Drug Targets 2011, 10(6):497-508. 10.2174/187152811798104872, 21999177.
39. Olive M, Harten I, Mitchell R, Beers JK, Djabali K, Cao K, Erdos MR, Blair C, Funke B, Smoot L, Gerhard-Herman M, Machan JT, Kutys R, Virmani R, Collins FS, Wight TN, Nabel EG, Gordon LB. Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. Arterioscler Thromb Vasc Biol 2010, 30(11):2301-2309. 10.1161/ATVBAHA.110.209460, 2965471, 20798379.
40. Komaki H, Hayashi YK, Tsuburaya R, Sugie K, Kato M, Nagai T, Imataka G, Suzuki S, Saitoh S, Asahina N, Honke K, Higuchi Y, Sakuma H, Saito Y, Nakagawa E, Sugai K, Sasaki M, Nonaka I, Nishino I. Inflammatory changes in infantile-onset LMNA-associated myopathy. Neuromuscul Disord 2011, 21(8):563-568. 10.1016/j.nmd.2011.04.010, 21632249.
41. Blanco FJ, Bernabéu C. The Splicing Factor SRSF1 as a Marker for Endothelial Senescence. Front Physiol 2012, 3:54. 3314196, 22470345.
42. Hacke W, Grond-Ginsbach C. Commentary on a GWAS: HDAC9 and the risk for ischaemic stroke. BMC Med 2012, 10:70. 10.1186/1741-7015-10-70, 3403977, 22776031.
43. Galiová G, Bártová E, Raska I, Krejcí J, Kozubek S. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A. Eur J Cell Biol 2008, 87(5):291-303. Epub 2008 Apr 8, 10.1016/j.ejcb.2008.01.013, 18396346.
44. Sackstein R. The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives. Curr Opin Hematol 2011, 18(4):239-248. 10.1097/MOH.0b013e3283476140, 3145154, 21546828.
45. Breitkreutz BJ, Stark C, Tyers M. Osprey: A Network Visualization System. Genome Biol 2003, 4(3):R22. http://biodata.mshri.on.ca/osprey/servlet/Index, 10.1186/gb-2003-4-3-r22, 153462, 12620107.
46. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. Biogrid: A General Repository for Interaction Datasets. Nucleic Acids Res 34:D535-539. http://thebiogrid.org/.
47. Bertrand AT, Chikhaoui K, Yaou RB, Bonne G. Clinical and genetic heterogeneity in laminopathies. Biochem Soc Trans 2011, 39(6):1687-1692. 10.1042/BST20110670, 22103508.
48. Genschel J, Schmidt HH. Mutations in the LMNA gene encoding lamin A/C. Hum Mutat 2000, 16(6):451-9. 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9, 11102973.